|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.690 USD | +4.32% |
|
+12.67% | +25.19% |
| 15/01 | Ocugen, Inc. - Special Call | |
| 15/01 | Ocugen Says Gene Therapy Reduced Lesion Growth by 46% in Eye Disease Trial | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 1.91 | 1.91 | 1.77 |
| Spread/Res. | -11.52% | -11.52% | -4.52% |
| Spread/Supp. | +14.19% | +25.19% | +70.09% |
| Support | 1.48 | 1.35 | 0.9936 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- OCGN Stock
- Charts Ocugen, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition